Celldex Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2010
Total Assets: $109.9M
Liabilities Breakdown FY2010
Total Liabilities: $34.7M
Asset Breakdown
Total Assets: $109.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $21.3M | 19.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $10.8M | 9.9% |
| Goodwill | $9.0M | 8.2% |
| Intangible Assets | $26.8M | 24.4% |
| Other Assets | $42.0M | 38.2% |
Liabilities Breakdown
Total Liabilities: $34.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $931.0K | 2.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $33.8M | 97.3% |